|
TWI659968B
(zh)
|
2013-03-14 |
2019-05-21 |
再生元醫藥公司 |
針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法
|
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
PL3204095T3
(pl)
|
2014-10-10 |
2019-10-31 |
Ablynx Nv |
Urządzenie do inhalacji do stosowania w terapii aerozolowej chorób układu oddechowego
|
|
RU2017115670A
(ru)
|
2014-10-10 |
2018-11-15 |
Аблинкс Н.В. |
Лечение инфекции рсв
|
|
US9340604B1
(en)
*
|
2014-10-29 |
2016-05-17 |
Aridis Pharmaceuticals, Inc. |
Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)
|
|
US20180171125A1
(en)
|
2015-06-25 |
2018-06-21 |
Sabic Global Technologies B.V. |
Polymer composition comprising linear low-density polyethylene
|
|
EP3317290A4
(en)
*
|
2015-07-02 |
2019-04-10 |
Spring Bank Pharmaceuticals, Inc. |
COMPOSITIONS AND METHOD FOR TREATING VIRUS INFECTION
|
|
TW202440904A
(zh)
|
2015-08-04 |
2024-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法（二）
|
|
JO3555B1
(ar)
|
2015-10-29 |
2020-07-05 |
Merck Sharp & Dohme |
جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
|
|
CN106496324B
(zh)
*
|
2015-11-30 |
2020-01-14 |
天津昊免生物技术有限公司 |
一种抗呼吸道合胞病毒的全人源抗体
|
|
WO2018039499A1
(en)
|
2016-08-24 |
2018-03-01 |
Regeneron Pharmaceuticals, Inc. |
Host cell protein modification
|
|
JP2020503843A
(ja)
|
2016-10-21 |
2020-02-06 |
アディマブ， エルエルシー |
抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
|
|
WO2018075954A2
(en)
|
2016-10-21 |
2018-04-26 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
|
CN110035771B
(zh)
*
|
2016-10-21 |
2024-03-08 |
阿迪马布有限责任公司 |
抗呼吸道合胞病毒抗体及其产生和使用方法
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
KR102659791B1
(ko)
|
2017-07-06 |
2024-04-23 |
리제너론 파마슈티칼스 인코포레이티드 |
당단백질을 만들기 위한 세포 배양 과정
|
|
WO2019075433A1
(en)
*
|
2017-10-13 |
2019-04-18 |
Adimab, Llc |
ANTIBODIES AGAINST SYNCYTIAL RESPIRATORY VIRUS AND METHODS FOR THEIR GENERATION AND USE
|
|
BR112020010615A2
(pt)
|
2017-12-22 |
2020-10-27 |
Regeneron Pharmaceuticals, Inc. |
produto farmacêutico proteico, método e sistema para caracterizar impurezas de produto farmacêutico proteico e de fármaco de baixo peso molecular, método para produzir um anticorpo, anticorpo, e, usos do método e do sistema
|
|
CN111936513A
(zh)
*
|
2018-01-31 |
2020-11-13 |
威斯塔解剖学和生物学研究所 |
用于抗呼吸道合胞病毒的核酸抗体构筑体
|
|
CN111655722A
(zh)
|
2018-01-31 |
2020-09-11 |
瑞泽恩制药公司 |
用于表征药物产品杂质的系统和方法
|
|
TW202311746A
(zh)
|
2018-02-02 |
2023-03-16 |
美商再生元醫藥公司 |
用於表徵蛋白質二聚合之系統及方法
|
|
MX2020008988A
(es)
|
2018-02-28 |
2020-09-28 |
Regeneron Pharma |
Sistemas y metodos para la identificacion de contaminantes virales.
|
|
US12253490B2
(en)
|
2018-03-19 |
2025-03-18 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
CA3089655C
(en)
|
2018-03-19 |
2026-01-20 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
US12259355B2
(en)
|
2018-03-19 |
2025-03-25 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
TW202016125A
(zh)
|
2018-05-10 |
2020-05-01 |
美商再生元醫藥公司 |
用於定量及調節蛋白質黏度之系統與方法
|
|
MY204234A
(en)
|
2018-08-27 |
2024-08-16 |
Regeneron Pharma |
Use of raman spectroscopy in downstream purification
|
|
AU2019333047A1
(en)
|
2018-08-30 |
2020-12-03 |
Regeneron Pharmaceuticals, Inc. |
Methods for characterizing protein complexes
|
|
US20210347885A1
(en)
*
|
2018-09-21 |
2021-11-11 |
The University Of North Carolina At Chapel Hill |
Synthetic binding agents for limiting permeation through mucus
|
|
WO2020124846A1
(zh)
*
|
2018-12-18 |
2020-06-25 |
珠海泰诺麦博生物技术有限公司 |
抗呼吸道合胞病毒的中和抗体及其应用
|
|
ES2942024T3
(es)
|
2019-01-16 |
2023-05-29 |
Regeneron Pharma |
Métodos para caracterizar enlaces disulfuro
|
|
CN111606993B
(zh)
*
|
2019-02-26 |
2022-06-28 |
中国科学院上海生命科学研究院 |
抗呼吸道合胞病毒的全人广谱中和抗体4f1及其应用
|
|
EP3969908A1
(en)
|
2019-05-13 |
2022-03-23 |
Regeneron Pharmaceuticals, Inc. |
Improved competitive ligand binding assays
|
|
EP4653865A3
(en)
|
2019-09-24 |
2026-02-18 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods for chromatography use and regeneration
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
WO2021108548A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous emulsions
|
|
MX2022008973A
(es)
|
2020-01-21 |
2022-08-11 |
Regeneron Pharma |
Metodos de desglicosilacion para electroforesis de proteinas glicosiladas.
|
|
AU2021332355A1
(en)
|
2020-08-31 |
2023-03-23 |
Regeneron Pharmaceuticals, Inc. |
Asparagine feed strategies to improve cell culture performance and mitigate asparagine sequence variants
|
|
FR3114970B1
(fr)
*
|
2020-10-08 |
2023-06-30 |
Univ Tours |
Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires
|
|
WO2022115588A1
(en)
|
2020-11-25 |
2022-06-02 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous membrane emulsification
|
|
JP2024500409A
(ja)
|
2020-12-17 |
2024-01-09 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
タンパク質封入マイクロゲルの作製
|
|
KR20230134117A
(ko)
|
2021-01-20 |
2023-09-20 |
리제너론 파마슈티칼스 인코포레이티드 |
세포 배양물에서 단백질 역가를 개선시키는 방법
|
|
IL305156A
(en)
|
2021-03-03 |
2023-10-01 |
Regeneron Pharma |
Systems and methods for quantifying and modifying protein viscosity
|
|
BR112023018665A2
(pt)
|
2021-03-26 |
2023-10-03 |
Regeneron Pharma |
Métodos e sistemas para desenvolvimento de protocolos de mistura
|
|
EP4348234B1
(en)
|
2021-06-01 |
2026-04-08 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
US20230077710A1
(en)
|
2021-09-08 |
2023-03-16 |
Regeneron Pharmaceuticals, Inc. |
HIGH-THROUGHPUT AND MASS-SPECTROMETRY-BASED METHOD FOR QUANTITATING ANTIBODIES AND OTHER Fc-CONTAINING PROTEINS
|
|
JP2024531800A
(ja)
|
2021-09-20 |
2024-08-29 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗体の不均一性を制御する方法
|
|
WO2023059800A2
(en)
|
2021-10-07 |
2023-04-13 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods of ph modeling and control
|
|
CA3230985A1
(en)
|
2021-10-07 |
2023-04-13 |
Ross BROWNE |
Ph meter calibration and correction
|
|
CA3236367A1
(en)
|
2021-10-26 |
2023-05-04 |
Michelle Lafond |
Systems and methods for generating laboratory water and distributing laboratory water at different temperatures
|
|
IL315548A
(en)
|
2022-03-18 |
2024-11-01 |
Regeneron Pharma |
Methods and systems for analyzing polypeptide variants
|
|
EP4634659A1
(en)
|
2022-12-16 |
2025-10-22 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for assessing chromatographic column integrity
|
|
WO2024158961A1
(en)
|
2023-01-25 |
2024-08-02 |
Regeneron Pharmaceuticals, Inc. |
Mass spectrometry-based characterization of antibodies co-expressed in vivo
|
|
US20240245779A1
(en)
|
2023-01-25 |
2024-07-25 |
Regeneron Pharmaceuticals, Inc. |
Methods of modeling liquid protein composition stability
|
|
US20240255519A1
(en)
|
2023-02-01 |
2024-08-01 |
Regeneron Pharmaceuticals, Inc. |
Asymmetrical flow field-flow fractionation with mass spectrometry for biomacromolecule analysis
|
|
US20240280551A1
(en)
|
2023-02-22 |
2024-08-22 |
Regeneron Pharmaceuticals, Inc. |
System suitability parameters and column aging
|
|
EP4704808A1
(en)
|
2023-05-01 |
2026-03-11 |
Regeneron Pharmaceuticals, Inc. |
Multidose antibody drug products using phenol or benzyl alcohol
|
|
TW202528736A
(zh)
|
2023-09-08 |
2025-07-16 |
美商再生元醫藥公司 |
用於評估層析管柱完整性的方法及系統
|
|
WO2025064403A2
(en)
|
2023-09-18 |
2025-03-27 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for developing chromatography protocols
|
|
CN121925272A
(zh)
|
2023-09-29 |
2026-04-24 |
瑞泽恩制药公司 |
利用受控成核进行冻干
|
|
WO2025085594A1
(en)
|
2023-10-18 |
2025-04-24 |
Regeneron Pharmaceuticals, Inc. |
Rapid purification of monoclonal antibody from in-process upstream cell culture material
|
|
US20250145662A1
(en)
|
2023-11-02 |
2025-05-08 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing lipase activity using stress
|
|
WO2025104604A1
(en)
|
2023-11-14 |
2025-05-22 |
Janssen Pharmaceuticals, Inc. |
Anti-respiratory syncytial virus antibodies and uses thereof
|
|
WO2025166281A1
(en)
|
2024-02-01 |
2025-08-07 |
Regeneron Pharmaceuticals, Inc. |
Platform for charge-detection mass spectrometry analysis of aavs
|
|
WO2025175164A1
(en)
|
2024-02-16 |
2025-08-21 |
Regeneron Pharmaceuticals, Inc. |
Methods of producing concentrated formulated drug substances comprising proteins, and concentrated formulated drug substance made by the methods
|
|
WO2025194126A1
(en)
*
|
2024-03-15 |
2025-09-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Respiratory syncytial virus (rsv) g and f antibodies with high rsv-neutralizing potency
|
|
TW202602489A
(zh)
|
2024-03-15 |
2026-01-16 |
美商再生元醫藥公司 |
作為經穩定的蛋白質調配物之賦形劑的聚山梨醇酯及聚氧乙烯山梨糖醇酐
|
|
WO2025259840A1
(en)
|
2024-06-13 |
2025-12-18 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for scaled chromatography
|
|
WO2026025028A1
(en)
|
2024-07-26 |
2026-01-29 |
Regeneron Pharmaceuticals, Inc. |
Methods of making ultra-high concentrated protein formulations using lyophilization
|
|
WO2026060350A1
(en)
|
2024-09-13 |
2026-03-19 |
Regeneron Pharmaceuticals, Inc. |
Methods of improving photo stability and controlling formation of hmw species in biologic formulations, and biologic formulations produced by the methods
|
|
WO2026076201A2
(en)
|
2024-10-03 |
2026-04-09 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods for producing therapeutic proteins using single pass tangential flow filtration for in-line concentration and volume reduction of production pools
|
|
WO2026080597A1
(en)
|
2024-10-08 |
2026-04-16 |
Regeneron Pharmaceuticals, Inc. |
Sustained delivery of biologics and non-aqueous manufacture of same
|